Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Fast Five Quiz: Plaque Psoriasis ... Biologic Failure in Psoriasis A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

The favorable data provided support for two ongoing phase III, randomized, placebo-controlled trials of ESK-001 in moderate/severe plaque psoriasis ... Treatment New targets and drugs are just ...

and I just want to help people as best I can." Effective treatment options for plaque psoriasis When treating plaque psoriasis, Dr. McCusker says many people use topical medications such as creams ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Proper diagnosis and treatment by a dermatologist is crucial for managing the condition effectively. Plaque ... by certain ...

Generalized pustular psoriasis may be ... mouth and no personal history of plaque psoriasis. Some environmental factors, including certain infections and medications, may also cause GPP ...

"The approval of NDUVRA (tapinarof cream) introduces a new treatment option for adult patients with mild to severe plaque psoriasis. In clinical trials, patients who achieved complete disease ...

1 "Young patients with plaque psoriasis face unique challenges due to the visible and uncomfortable nature of the disease, making effective treatment options that align with their needs and ...

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study. The randomized ...